SCHEMBL19702018

SCHEMBL19702018

COCC(C)N1CC2CN(c3cccc(C(C)C)c3)CC2C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.43
PIK3CD O00329 1/20 0.42
HRH3 Q9Y5N1 1/20 0.38
GRM2 Q14416 1/20 0.38
VCP P55072 1/20 0.36
LPAR5 Q9H1C0 2/20 0.36
RXRA P19793 6/20 0.36
GRIN1 Q05586 6/20 0.36
GRIN2B Q13224 6/20 0.36
DRD2 P14416 1/20 0.36
HTR2A P28223 1/20 0.36
HRH1 P35367 1/20 0.36
HDAC4 P56524 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
ALDH1A1 P00352 2/20 0.35
RECQL P46063 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ACACB O00763 1/20 0.35
HTR7 P34969 1/20 0.34
TMEM97 Q5BJF2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22054805 0.86 PIK3CD (0.43) NOTUMPIK3CDVCPDRD2HTR2A
SCHEMBL19702015 0.82 NOTUM (0.50) NOTUMPIK3CDHRH3GRM2VCP
SCHEMBL19702011 0.78 NOTUM (0.51) NOTUMHRH3GRM2
SCHEMBL19702016 0.75 NOTUM (0.47) NOTUMPIK3CDHRH3GRM2VCP
SCHEMBL19702013 0.74 BPTF (0.57) NOTUMHRH3
SCHEMBL19702010 0.73 NOTUM (0.50) NOTUMPIK3CDHRH3GRM2ALDH1A1
SCHEMBL25752839 0.73 NOTUM (0.55) NOTUMHRH3GRM2RXRAGRIN1
SCHEMBL19702012 0.72 NOTUM (0.55) NOTUMPIK3CDHRH3ACACB
SCHEMBL19702014 0.72 NOTUM (0.49) NOTUMPIK3CDHRH3GRM2VCP
SCHEMBL22187756 0.69 NOTUM (0.51) NOTUMHRH3GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170355707-A1 BICYCLIC HETEROARYL AMINE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2017-12-14 US disclosed
US-20170355707-A1 BICYCLIC HETEROARYL AMINE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2017-12-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170355707-A1 BICYCLIC HETEROARYL AMINE COMPOUNDS PIK3R3, JAK2, JAK3 NOTUM 3221/4885PIK3CD 14/4885HRH3 61/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.